StockTipsArenaBeta

BUY Indegene Limited — ICICI Securities

BUYIndegene Limited
Indegene share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)2 May 2026via Institutional / Brokerage Research

Entry₹499.75Inferred
Target₹620
Total upside +24.06% (call closed)
Stop lossNot given
Exit₹62025 Sept 2026, 12:09 pm
Target hit+24.06%0.00%upside left
Follow ICICI Securities for new calls(67% target hit, 1026 closed calls)Get alertsWatch INDGN for new buy/sell callsGet alertsSee 3 active Long-term calls on INDGNSee 214 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 25 Sept 2026
6 supporting9 neutral1 opposing
Supports the BUY call (6)

2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·25 Sept · today

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·23 Sept · 2d ago

Neutral / worth noting (9)

Indegene hosts Digital Summit 2026 to drive AI outcomes in life sciences

NewsGoogle News·23 Sept · yesterday

(opens in new tab)

Indegene showcases AI operationalisation at Digital Summit 2026

NewsGoogle News·23 Sept · yesterday

(opens in new tab)

Indegene Summit 2026: AI, Life Sciences, and Industry Leadership

NewsGoogle News·23 Sept · yesterday

(opens in new tab)

Indegene Inc., a subsidiary, received preliminary court approval for a class action settlement related to the Telephone Consumer Protection Act. The court approved the notice process and set a final h

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·31 Aug · 3w ago

(opens in new tab)

Indegene Inc., a subsidiary, received preliminary court approval for a class-action settlement related to TCPA litigation. The court approved the notice process and set a final hearing for Jan 2027. T

BSE · Company Update·31 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Indegene

All analyst calls on Indegene

More from ICICI Securities

Every call and its outcome